Vincristine toxicity with co-administration of triazole antifungals during induction therapy for pediatric acute lymphoblastic leukemia.

被引：0
|
作者：
Smitherman, Andrew Brian
Troy, Michael
Beach, Cassidy
Deal, Allison Mary
Gold, Stuart H.
机构：
[1] Univ N Carolina, Chapel Hill, NC USA
[2] UNC Lineberger Comprehens Canc Ctr, Biostatist Core Facil, Chapel Hill, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.10535
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10535
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Vincristine-induced paralytic ileus during induction therapy of treatment protocols for acute lymphoblastic leukemia in adult patients
    Yasu, Takeo
    Ohno, Nobuhiro
    Kawamata, Toyotaka
    Kurokawa, Yosuke
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2016, 54 (06) : 471 - 473
  • [32] Targeted Therapy in the Treatment of Pediatric Acute Lymphoblastic Leukemia-Therapy and Toxicity Mechanisms
    Lejman, Monika
    Kusmierczuk, Kinga
    Bednarz, Kinga
    Ostapinska, Katarzyna
    Zawitkowska, Joanna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (18)
  • [33] Neutropenic fever prophylaxis during induction therapy for acute myeloid leukemia.
    Nabbout, Nassim H.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [34] Genetic variants in MDR1 and CYP3A5 and vincristine toxicity in children with acute lymphoblastic leukemia.
    Te Loo, D. M.
    Hagleitner, M. M.
    van Schie, R.
    van der Sluis, I. M.
    Coenen, M. J.
    Hoogerbrugge, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [35] SEVERE TOXICITY LIMITS INTENSIFICATION OF INDUCTION THERAPY FOR ACUTE LYMPHOBLASTIC-LEUKEMIA
    WEISS, M
    TELFORD, P
    KEMPIN, S
    KRITZ, A
    SOGOLOFF, H
    GEE, T
    BERMAN, E
    SCHEINBERG, D
    LITTLE, C
    GAYNOR, J
    BELANGER, C
    BERTINO, J
    ANDREEFF, M
    MCKENZIE, S
    CLARKSON, B
    LEUKEMIA, 1993, 7 (06) : 832 - 837
  • [36] Substitution with doxorubicin for daunorubicin during induction for high risk pediatric acute lymphoblastic leukemia results in increased toxicity
    Gardner, Rebecca A.
    Thomson, Blythe
    Hawkins, Douglas S.
    PEDIATRIC BLOOD & CANCER, 2013, 60 (02) : 338 - 339
  • [37] Toxicity of dexamethasone (DEX) vs prednisone (PRED) during induction chemotherapy for pediatric acute lymphoblastic leukemia (ALL)
    Belgaumi, AF
    Al-Bakrah, M
    Al-Mahr, M
    Al-Jefri, A
    Al-Musa, AR
    Saleh, M
    Salim, MF
    OSman, M
    Osman, L
    El-Solh, H
    PEDIATRIC RESEARCH, 2002, 51 (04) : 234A - 234A
  • [38] Vincristine pharmacokinetics pathway and neurotoxicity during early phases of treatment in pediatric acute lymphoblastic leukemia
    Lopez-Lopez, Elixabet
    Gutierrez-Camino, Angela
    Astigarraga, Itziar
    Navajas, Aurora
    Echebarria-Barona, Aizpea
    Garcia-Miguel, Purificacion
    Garcia de Andoin, Nagore
    Lobo, Carmen
    Guerra-Merino, Isabel
    Martin-Guerrero, Idoia
    Garcia-Orad, Africa
    PHARMACOGENOMICS, 2016, 17 (07) : 731 - 741
  • [39] MEDICATION INDUCED DIABETES DURING INDUCTION THERAPY IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA: IMPACT OF RISK GROUPING
    Ross, Katie
    Kulkarni, Ketan
    Pinto, Teresa
    Macdonald, Tamara
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [40] Assessment of early response to induction therapy lacks prognostic significance in infant acute lymphoblastic leukemia.
    Vora, A
    Will, A
    Reid, M
    Lilleyman, J
    McDonald-Clink, J
    Chessells, J
    BLOOD, 2000, 96 (11) : 463A - 463A
12345